Major Researches

Motonori Tsuji*. Potential Anti-SARS-CoV-2 Drug Candidates Identified through Virtual Screening of the ChEMBL Database for Compounds That Target the Main Coronavirus Protease. FEBS Open Bio, 10, 995-1004, 2020.

Motonori Tsuji*. Antagonist-Perturbation Mechanism for Activation Function-2 Fixed Motifs: Active Conformation and Docking Mode of Retinoid X Receptor Antagonists. J. Comput. Aided Mol. Des., 31, 577-585, 2017.

Motonori Tsuji*, Koichi Shudo, Hiroyuki Kagechika. Identifying the Receptor Subtype Selectivity of Retinoid X and Retinoic Acid Receptors via Quantum Mechanics. FEBS Open Bio., 7, 391-396, 2017.

Motonori Tsuji*. A Ligand-Entry Surface of the Nuclear Receptor Superfamily Consists of the Helix H3 of the Ligand-Binding Domain. J. Mol. Graph. Model., 62, 262-275, 2015.

Motonori Tsuji*, Koichi Shudo, Hiroyuki Kagechika. Docking Simulations Suggest that all-trans Retinoic Acid Could Bind to Retinoid X Receptors. J. Comput. Aided Mol. Des. 29, 975-988, 2015.

Motonori Tsuji*.Geometrical Dependence of the Highest Occupied Molecular Orbital in Bicyclic Systems:p Facial Stereoselectivity of Bicyclic and Tricyclic Olefins. Asian J. Org. Chem.,4, 659-673, 2015.

Motonori Tsuji*. Local Motifs Involved in the Canonical Structure of the Ligand-Binding Domain in the Nuclear Receptor Superfamily. J. Struct. Biol., 185, 355-365, 2014.

Motonori Tsuji*. Most Stable Conformation of the Cyclopropane Ring Attached at a Carbon Atom in a 1,2-Dicarba-closo-dodecaborane(12) System. J. Org. Chem., 69, 4063-4074, 2004.

Motonori Tsuji*. On Attempts at Generation of Carboranyl Carbocation. J. Org. Chem., 68, 9589-9597, 2003.

Motonori Tsuji*. SEITAIKOUBUNSHI NIOKERU SOUGOSAYOUBUI NO YOSOKUHOUHOU, JP 2007-299125, 2006.